These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
221 related articles for article (PubMed ID: 31809406)
1. Testing Unconventional Matrices to Monitor for Prenatal Exposure to Heroin, Cocaine, Amphetamines, Synthetic Cathinones, and Synthetic Opioids. Carlier J; La Maida N; Di Trana A; Huestis MA; Pichini S; Busardò FP Ther Drug Monit; 2020 Apr; 42(2):205-221. PubMed ID: 31809406 [TBL] [Abstract][Full Text] [Related]
2. Monitoring Prenatal Exposure to Buprenorphine and Methadone. Di Trana A; La Maida N; Tittarelli R; Huestis MA; Pichini S; Busardò FP; Carlier J Ther Drug Monit; 2020 Apr; 42(2):181-193. PubMed ID: 31425444 [TBL] [Abstract][Full Text] [Related]
3. Bioanalysis for cocaine, opiates, methadone, and amphetamines exposure detection during pregnancy. Concheiro M; Lendoiro E; de Castro A; Gónzalez-Colmenero E; Concheiro-Guisan A; Peñas-Silva P; Macias-Cortiña M; Cruz-Landeira A; López-Rivadulla M Drug Test Anal; 2017 Jun; 9(6):898-904. PubMed ID: 27595432 [TBL] [Abstract][Full Text] [Related]
5. Alternative matrices for cocaine, heroin, and methadone in utero drug exposure detection. Concheiro M; González-Colmenero E; Lendoiro E; Concheiro-Guisán A; de Castro A; Cruz-Landeira A; López-Rivadulla M Ther Drug Monit; 2013 Aug; 35(4):502-9. PubMed ID: 23851907 [TBL] [Abstract][Full Text] [Related]
6. Testing for fetal exposure to illicit drugs using umbilical cord tissue vs meconium. Montgomery D; Plate C; Alder SC; Jones M; Jones J; Christensen RD J Perinatol; 2006 Jan; 26(1):11-4. PubMed ID: 16281047 [TBL] [Abstract][Full Text] [Related]
7. [Alternative biological materials to detect prenatal exposure to drugs of abuse in the third trimester of pregnancy]. García-Serra J; Ramis J; Simó S; Joya X; Pichini S; Vall O; García-Algar O An Pediatr (Barc); 2012 Nov; 77(5):323-8. PubMed ID: 22513392 [TBL] [Abstract][Full Text] [Related]
8. Maternal Hair and Neonatal Meconium to Assess Gestational Consumption and Prenatal Exposure to Drugs of Abuse and Psychoactive Drugs. Cortes L; Almeida L; Sabra S; Muniesa M; Busardo FP; Garcia-Algar O; Gomez-Roig MD Curr Pharm Biotechnol; 2018; 19(2):136-143. PubMed ID: 29621962 [TBL] [Abstract][Full Text] [Related]
9. Methadone, cocaine, opiates, and metabolite disposition in umbilical cord and correlations to maternal methadone dose and neonatal outcomes. de Castro A; Jones HE; Johnson RE; Gray TR; Shakleya DM; Huestis MA Ther Drug Monit; 2011 Aug; 33(4):443-52. PubMed ID: 21743375 [TBL] [Abstract][Full Text] [Related]
10. Novel methods for the detection of drug and alcohol exposure during pregnancy: implications for maternal and child health. Koren G; Hutson J; Gareri J Clin Pharmacol Ther; 2008 Apr; 83(4):631-4. PubMed ID: 18288086 [TBL] [Abstract][Full Text] [Related]
11. Drug testing in biological samples vs. maternal surveys for the detection of substance use during whole pregnancy. González-Colmenero E; Concheiro-Guisán A; Lorenzo-Martínez M; Concheiro M; Lendoiro E; de-Castro-Ríos A; Cañizo-Vázquez D; Martínez-Reglero C; Fernández-Lorenzo JR J Addict Dis; 2021; 39(2):175-182. PubMed ID: 33043834 [TBL] [Abstract][Full Text] [Related]
12. Umbilical cord monitoring of in utero drug exposure to buprenorphine and correlation with maternal dose and neonatal outcomes. Concheiro M; Jones HE; Johnson RE; Choo R; Shakleya DM; Huestis MA J Anal Toxicol; 2010 Oct; 34(8):498-505. PubMed ID: 21819795 [TBL] [Abstract][Full Text] [Related]
13. Comparison of umbilical cord tissue and meconium for the confirmation of in utero drug exposure. Colby JM Clin Biochem; 2017 Sep; 50(13-14):784-790. PubMed ID: 28288850 [TBL] [Abstract][Full Text] [Related]
14. Assessment of biological matrices for the detection of in utero cannabis exposure. Concheiro M; Gutierrez FM; Ocampo A; Lendoiro E; González-Colmenero E; Concheiro-Guisán A; Peñas-Silva P; Macías-Cortiña M; Cruz-Landeira A; López-Rivadulla M; de-Castro-Ríos A Drug Test Anal; 2021 Jul; 13(7):1371-1382. PubMed ID: 33750017 [TBL] [Abstract][Full Text] [Related]
15. Comparison of Biological Screening and Diagnostic Indicators to Detect In Utero Opiate and Cocaine Exposure Among Mother-Infant Dyads. Stabler M; Giacobbi P; Chertok I; Long L; Cottrell L; Yossuck P Ther Drug Monit; 2017 Dec; 39(6):640-647. PubMed ID: 28937537 [TBL] [Abstract][Full Text] [Related]
16. Quantification of Methamphetamine «Shabu» in Biological Matrices to Detect Prenatal Exposure: A Case Report and a Literature Review. Jarque P; Roca A; Gomila I; Noce V; Barcelo B; Klein J Curr Pharm Biotechnol; 2018; 19(2):163-174. PubMed ID: 29701148 [TBL] [Abstract][Full Text] [Related]
17. Prevalence of cathinones and other new psychoactive substances in hair of parents and children of families with known or suspected parental abuse of conventional illegal drugs. Niebel A; Pragst F; Krumbiegel F; Hartwig S Forensic Sci Int; 2022 Feb; 331():111148. PubMed ID: 34923263 [TBL] [Abstract][Full Text] [Related]
18. Substance abuse in pregnant women: making improved detection a good clinical outcome. Araojo R; McCune S; Feibus K Clin Pharmacol Ther; 2008 Apr; 83(4):520-2. PubMed ID: 18349872 [TBL] [Abstract][Full Text] [Related]
19. Biological matrices for the evaluation of in utero exposure to drugs of abuse. Lozano J; García-Algar O; Vall O; de la Torre R; Scaravelli G; Pichini S Ther Drug Monit; 2007 Dec; 29(6):711-34. PubMed ID: 18043469 [TBL] [Abstract][Full Text] [Related]
20. Effects of addictive substances during pregnancy and infancy and their analysis in biological materials. Płotka J; Narkowicz S; Polkowska Z; Biziuk M; Namieśnik J Rev Environ Contam Toxicol; 2014; 227():55-77. PubMed ID: 24158579 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]